I would pay closer attention to GP2 since it's closer to NEU VAX that its being based off the HER2 protein. In it's trials it did better than NEU VAX showing similiar promising results and only validates the science behind the vaccine.
Leave the guy alone already.
And it being very similar to that of E75 which made 50% I say that only validates our science in meeting only 30% for approval.
Your wrong its a Wonder twins formation followed by The Penguin.
Call it what you want but if your p value equates to 3.5 on those patients then a company conducting a phase 3 better make sure it revolves around those subset of patients.